trending Market Intelligence /marketintelligence/en/news-insights/trending/6qqpu9d8mmpjmekfrmc5ja2 content esgSubNav
In This List

Leap Therapeutics raises $16.1M via common stock offering

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Leap Therapeutics raises $16.1M via common stock offering

Leap Therapeutics Inc. raised $16.1 million in gross proceeds from the sale of 2,146,667 common shares in an underwritten public offering.

The shares sold included 280,000 shares sold pursuant to the full exercise of the underwriters' option to buy additional shares.

Raymond James & Associates Inc. and Ladenburg Thalmann acted as book-running managers for the offering.